| scholarly article | Q13442814 |
| P2093 | author name string | J. J. Gordon | |
| L. Leadbeater | |||
| M. P. Maidment | |||
| P2860 | cites work | The prophylactic use of 1-methyl, 2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoning | Q40075996 |
| On an approximate method of determining the median effective dose and its error, in the case of a quantal response | Q41920233 | ||
| The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate | Q71666682 | ||
| A specific antidote against lethal alkyl phosphate intoxication. V. Antidotal properties | Q74552674 | ||
| ANTIDOTAL ACTION OF PYRIDINIUM OXIMES IN ANTICHOLINESTERASE POISONING; COMPARATIVE EFFECTS OF SOMAN, SARIN, AND NEOSTIGMINE ON NEUROMUSCULAR FUNCTION | Q76616153 | ||
| TOXOGONIN IN SARIN, SOMAN AND TABUN POISONING | Q78334573 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | poisoning | Q114953 |
| pharmacology | Q128406 | ||
| organophosphate | Q411097 | ||
| P304 | page(s) | 207-216 | |
| P577 | publication date | 1978-01-01 | |
| P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
| P1476 | title | The protection of animals against organophosphate poisoning by pretreatment with a carbamate | |
| P478 | volume | 43 |
| Q48357028 | A novel agonist binding site on nicotinic acetylcholine receptors |
| Q44188078 | Active avoidance behavior in guinea pigs: Effects of physostigmine and scopolamine |
| Q69538269 | Acute toxicity of pyridostigmine in rats: histological findings |
| Q34047526 | Anaesthesia and critical care considerations in nerve agent warfare trauma casualties |
| Q48644238 | Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine |
| Q41172623 | Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms |
| Q31948188 | Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig. |
| Q50500138 | Carbamate protection of AChE against inhibition by agricultural chemicals. |
| Q51776481 | Carbamates, atropine, and diazepam: Effects on performance in the running rat |
| Q44536803 | Carbamoylated enzyme reversal as a means of predicting pyridostigmine protection against soman |
| Q44097191 | Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m-toluamide (DEET) in rats |
| Q46735139 | Cardiorespiratory function in nerve agent poisoned and oxime+atropine treated guinea-pigs: effect of pyridostigmine pretreatment |
| Q45818908 | Cerebral blood flow and metabolism in soman-induced convulsions |
| Q44286742 | Cholinolytic antagonism to the disruptive effects of oral low doses of pyridostigmine on simple discrimination performance in rats |
| Q48375922 | Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats |
| Q46955330 | Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning |
| Q44277818 | Design of physostigmine-loaded polymeric microparticles for pretreatment against exposure to organophosphate agents. |
| Q44633690 | Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of pyridostigmine bromide from guinea pig plasma |
| Q93657229 | Distribution of 3H-soman in mice |
| Q71783687 | Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning |
| Q70718628 | Effect of pyridostigmine pretreatment, HI-6 and Toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure |
| Q41768272 | Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication |
| Q48573423 | Effectiveness of procyclidine in combination with carbamate prophylactics against diisopropylfluorophosphate poisoning |
| Q43578857 | Effects of Huperzine used as pre-treatment against soman-induced seizures |
| Q42273647 | Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman |
| Q48684961 | Effects of chronic administration of huperzine A on memory in guinea pigs |
| Q42730181 | Effects of combinational prophylactics composed of physostigmine and procyclidine on soman-induced lethality, seizures and brain injuries |
| Q48220045 | Effects of pyridostigmine and cholinolytics on cholinesterase and acetylcholine in Soman poisoned rats |
| Q43938375 | Effects of selected anticholinergics on acoustic startle response in rats |
| Q39693679 | Effects of subacute feeding of carbaryl on mixed function oxidase and on acute toxicity of parathion and propoxur in rats |
| Q39254375 | Efficacy of Pro-PAM (N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride) as a prophylaxis against organophosphate poisoning |
| Q48319674 | Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 1: Guinea pigs challenged with VX |
| Q52492491 | Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation |
| Q67986738 | Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys |
| Q56092142 | FIELD STUDIES ON PESTICIDES AND BIRDS: UNEXPECTED AND UNIQUE RELATIONS |
| Q45834905 | In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates |
| Q43938358 | Intramuscular diazepam pharmacokinetics in soman-exposed guinea pigs |
| Q37760148 | Manmade disasters. |
| Q73553269 | Mapping of cortical metabolic activation in soman-induced convulsions in rats |
| Q70340339 | Method for isolation and determination of pyridostigmine and metabolites in urine and blood |
| Q77468576 | Neuromuscular responses to pyridostigmine bromide in organotypic spinal cord-muscle culture |
| Q41629826 | Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology |
| Q81651284 | Organophosphate and carbamate poisoning |
| Q37989116 | Organophosphorus hydrolase as an in vivo catalytic nerve agent bioscavenger |
| Q34429558 | Perioperative care of children with nerve agent intoxication |
| Q44937269 | Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman |
| Q46451447 | Pharmacokinetics of Pyridostigmine in Dogs |
| Q44365808 | Pharmacokinetics of intramuscularly administered biperiden in guinea pigs challenged with soman |
| Q44098523 | Pharmacological antagonism of lethal effects induced by O-isobutyl S-[2-(diethylamino)ethyl]methylphosphonothioate |
| Q44184701 | Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig |
| Q42849990 | Prevention of physostigmine-induced lethality by the opioid analgesic meptazinol in the mouse |
| Q52277400 | Protection against both lethal and behavioral effects of soman. |
| Q48637568 | Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine |
| Q41655402 | Protection by a carbamate against inactivation of cholinesterase and against the induction of supersensitivity of the ileum to acetylcholine produced by repeated administration of an organophosphate |
| Q46734858 | Protection from lethality and behavioral incapacitation resulting from intoxication by soman (pinacolyl methylphosphonofluoridate) and treatment with atropine sulfate and 2-PAM chloride in the guinea pig, cavia porcellus |
| Q48736007 | Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine |
| Q41106052 | Protection of guinea pigs against soman poisoning with ferrocene carbamate |
| Q43458260 | Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide |
| Q92891408 | Pyridostigmine bromide and stress interact to impact immune function, cholinergic neurochemistry and behavior in a rat model of Gulf War Illness |
| Q52532424 | Recovery of brain and plasma cholinesterase activities in ducklings exposed to organophosphorus pesticides |
| Q48324524 | Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat. |
| Q52533481 | Response of muscarinic cholinoceptors of guinea pig brain and ileum to chronic administration of carbamate or organophosphate cholinesterase inhibitors |
| Q34775146 | Review of the value of huperzine as pretreatment of organophosphate poisoning |
| Q31679791 | SCH 23390 affords protection against soman-evoked seizures in the freely moving guinea-pig: a concomitant neurochemical, electrophysiological and behavioural study |
| Q73363268 | Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs |
| Q42211457 | Spontaneous and oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates |
| Q56834847 | Study of muscular effects of short-term pyridostigmine treatment in resting and exercising rats |
| Q44098520 | Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity |
| Q43613185 | Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability |
| Q43613188 | Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity |
| Q52187814 | Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects. |
| Q48164873 | Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication |
| Q36673752 | Tacrine: A pharmacological review |
| Q36455148 | The Effects of Ingestion of 60 mg Pyridostigmine Bromide on Contrast Sensitivity in Man |
| Q71725173 | The delayed neuropathic effects of nerve agents and some other organophosphorus compounds |
| Q48581655 | The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats |
| Q51853218 | The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig |
| Q27691305 | The pharmacology and therapeutic potential of (-)-huperzine A. |
| Q41451713 | The present approaches to the development of prophylactic and therapeutic antidotes against nerve agents |
| Q39257982 | The protection of primates against soman poisoning by pretreatment with pyridostigmine |
| Q39257976 | The reversal by pyridostigmine of neuromuscular block produced by soman |
| Q44576112 | Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation |
| Q46945443 | Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats. |
| Q44547063 | Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration |
| Q42624321 | Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine? |
| Q69786978 | Urinary pharmacokinetics of physostigmine in the rat |
| Q44313377 | Use of the accelerating rotarod for assessment of motor performance decrement induced by potential anticonvulsant compounds in nerve agent poisoning |
| Q40139403 | VX Penetration Following Percutaneous Poisoning: A Dermal Microdialysis Study in the Guinea Pig. |
| Q46612756 | Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride. |
Search more.